Funds holding “CRISPR Therapeutics AG”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
2 positions across 2 funds, 2 distinct securities (bonds, share classes and derivatives of the same issuer are listed separately). Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| GLQ Clough Global Equity Fund Global Equity | CRISPR Therapeutics AG | H17182108 | EC | 1.08% | $2M | Jul 31, 2026 | full (91 positions) |
| AVK Advent Convertible & Income Fund Convertible Securities | CRISPR THERAPEUTICS AG | 226712AA5 | DBT | 0.09% | $701K | Jul 31, 2026 | full (466 positions) |
Matching position names
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.